RUNX2 and gastric cancer: In another gastric cancer study, RUNX2 was found to promote metastasis through the upregulation of COL1A1 expression, with patients displaying elevated levels of both RUNX2 and COL1A1 experiencing reduced survival times, thereby indicating a poor prognosis [111].